Skip to content

D&A at other companies

Baxter International logo
Baxter InternationalBAX
$237M-4.0%
DaVita logo
DaVitaDVA
$177.83M+0.8%
Medtronic logo
MedtronicMDT
$716M-14.8%
InfuSystem Holdings logo
InfuSystem HoldingsINFU
$3.04M-0.9%
Haemonetics logo
HaemoneticsHAE
$27.32M-3.2%
CorMedix logo
CorMedixCRMD
$10.54M+6,409%

Other financials

Income statement

See full
Revenue$27.9M-6.3%
Gross profit$12.1M+9.3%
Operating income-$16.9M-3.2%
Net income-$19.0M+26.4%
EPS (diluted)-$1.03+71.9%

Balance sheet

See full
Cash & equivalents$30.6M-59.7%
Total debt$101.6M+3.5%
Total equity$111.7M-34.3%
Total assets$249.5M-17.2%

Cash flow

See full
Operating cash flow-$12.8M+50.0%
CapEx$65.0K-47.2%
Free cash flow-$12.9M+49.9%

Valuation

See full
Market cap$80.08M-75.5%
Enterprise value$151.13M-61.9%
P/S0.7×-2.1×

Profitability

See full
Gross margin40.6%+4.7pp
Operating margin-57.2%-12.9pp
Net margin-63.7%-16.7pp
FCF margin-29.1%-11.5pp

Returns & leverage

See full
Return on equity-53.2%-14.8pp
Debt / equity0.9×+0.3×
Current ratio6.3×-2.1×

Where this comes from

Reported directly by Outset Medical, Inc. in its filing.

Tagged under the XBRL concept us-gaap:DepreciationDepletionAndAmortization.

The official record: Outset Medical, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Outset Medical, Inc.'s d&a.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Outset Medical, Inc.'s D&A?
Outset Medical, Inc. (OM) reported D&A of $795K in Q1 2026.
How has Outset Medical, Inc.'s D&A changed year-over-year?
Outset Medical, Inc.'s D&A decreased by 38.6% year-over-year, from $1.29M to $795K.
What is the long-term trend for Outset Medical, Inc.'s D&A?
Over 4 years (2021 to 2025), Outset Medical, Inc.'s D&A has grown at a -4.2% compound annual growth rate (CAGR), from $5.16M to $4.34M.
What does D&A mean?
Total non-cash depreciation of tangible assets and amortization of intangible assets — the largest add-back to net income in the operating cash flow reconciliation.